Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Eur J Obstet Gynecol Reprod Biol

Retrieve available abstracts of 74 articles:
HTML format



Single Articles


    November 2020
  1. TANG X, Zhang X, Liu X, Zheng T, et al
    A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:256-262.
    PubMed     Abstract available


    October 2020
  2. KONSGEN D, Klinkmann G, Kaul A, Diesing K, et al
    Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:154-159.
    PubMed     Abstract available


  3. ZHAO J, Wu J, Zuo W, Kang S, et al
    A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:183-189.
    PubMed     Abstract available


  4. FERRARI F, Ficarelli S, Forte S, Valenti G, et al
    Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:211-221.
    PubMed     Abstract available


    June 2020
  5. PERGIALIOTIS V, Thomakos N, Frountzas M, Haidopoulos D, et al
    Perioperative blood transfusion and ovarian cancer survival rates: A meta-analysis based on univariate, multivariate and propensity score matched data.
    Eur J Obstet Gynecol Reprod Biol. 2020;252:137-143.
    PubMed     Abstract available


    April 2020
  6. DELANGLE R, Rossard L, Cirier J, Delvallee J, et al
    Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?
    Eur J Obstet Gynecol Reprod Biol. 2020 Apr 24. pii: S0301-2115(20)30234.
    PubMed     Abstract available


  7. HSIAO SM
    Letter to the Editor on "A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy".
    Eur J Obstet Gynecol Reprod Biol. 2020;247:257.
    PubMed    


    January 2020
  8. RUDAITIS V, Mikliusas V, Januska G, Jukna P, et al
    The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:26-31.
    PubMed     Abstract available


    December 2019
  9. LECOINTRE L, Velten M, Lodi M, Saadeh R, et al
    Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).
    Eur J Obstet Gynecol Reprod Biol. 2019;245:64-72.
    PubMed     Abstract available


    November 2019
  10. OTIFY M, Laios A, Elshamy T, D'Angelo A, et al
    A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:120-127.
    PubMed     Abstract available


  11. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed     Abstract available


  12. RETTENMAIER MA, Micha JP, Bohart R, Goldstein BH, et al
    A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:101-105.
    PubMed     Abstract available


    October 2019
  13. NAMAZOV A, Gemer O, Helpman L, Hag-Yahia N, et al
    The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:120-124.
    PubMed     Abstract available


  14. VAN HEERDEN J, Tjalma WA
    The multidisciplinary approach to ovarian tumours in children and adolescents.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:103-110.
    PubMed     Abstract available


    September 2019
  15. BENITO V, Lubrano A, Andujar M, Mori M, et al
    Management of endometrial cancer in patients aged 80 years and older: Identifying patients who may benefit from a curative treatment.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:36-42.
    PubMed     Abstract available


  16. WANG Y, Sun H, Yu A, Zhu T, et al
    Association between chemotherapy and disease-specific survival in women with borderline ovarian tumors: A SEER-based study.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:92-98.
    PubMed     Abstract available


  17. NASIOUDIS D, Holcomb K
    Incidence of isolated para-aortic lymph node metastasis in early stage endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:43-46.
    PubMed     Abstract available


    August 2019
  18. REISER E, Aust S, Seebacher V, Reinthaller A, et al
    Gamma-glutamyltransferase as a preoperative differential diagnostic marker in patients with adnexal mass.
    Eur J Obstet Gynecol Reprod Biol. 2019;239:16-20.
    PubMed     Abstract available


    July 2019
  19. TIMMERMANS M, Zwakman N, Sonke GS, Van de Vijver KK, et al
    Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:364-369.
    PubMed     Abstract available


  20. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
    A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:310-315.
    PubMed     Abstract available


  21. TOZZI R, Casarin J, Baysal A, Pinelli C, et al
    Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:215-219.
    PubMed     Abstract available


  22. FALCONE F, Normanno N, Losito NS, Scognamiglio G, et al
    Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:220-225.
    PubMed     Abstract available


    June 2019
  23. ZHU X, Yang H, Lang J, Zhang Y, et al
    Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:103-108.
    PubMed     Abstract available


    May 2019
  24. NASIOUDIS D, Wilson E, Mastroyannis SA, Latif NA, et al
    Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors.
    Eur J Obstet Gynecol Reprod Biol. 2019;238:86-89.
    PubMed     Abstract available


    April 2019
  25. BOGANI G, Matteucci L, Tamberi S, Ditto A, et al
    RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy.
    Eur J Obstet Gynecol Reprod Biol. 2019;237:93-99.
    PubMed     Abstract available


    March 2019
  26. LAVOUE V, Huchon C, Akladios C, Alfonsi P, et al
    Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 15. pii: S0301-2115(19)30128.
    PubMed     Abstract available


  27. FISCHETTI A, Rutigliani M, Romano N, Marinaro EL, et al
    Imaging findings of ovarian leiomyosarcoma with histopathologic correlations.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 12. pii: S0301-2115(19)30116.
    PubMed     Abstract available


    January 2019
  28. KAJIYAMA H, Suzuki S, Yoshikawa N, Kawai M, et al
    Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2019;234:131-136.
    PubMed     Abstract available


    October 2018
  29. OTSUKA I
    Development and rapid growth of retroperitoneal leiomyoma during carboplatin/paclitaxel chemotherapy in an ovarian cancer patient.
    Eur J Obstet Gynecol Reprod Biol. 2018 Oct 19. pii: S0301-2115(18)31050.
    PubMed    


  30. HUANG J, Chen J, Huang Q
    Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2018;231:35-42.
    PubMed     Abstract available


    September 2018
  31. BASTU E, Onder S, Demiral I, Ozsurmeli M, et al
    Distinguishing the progression of an endometrioma: Benign or malignant?
    Eur J Obstet Gynecol Reprod Biol. 2018;230:79-84.
    PubMed     Abstract available


  32. HABEK D, Cenkovcan M, Jandric D, Stanic G, et al
    Ovarian hemangioma with Meigs' syndrome.
    Eur J Obstet Gynecol Reprod Biol. 2018 Sep 5. pii: S0301-2115(18)30961.
    PubMed    


    June 2018
  33. FELSINGER M, Minar L, Weinberger V, Rovny I, et al
    Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;228:154-160.
    PubMed     Abstract available


  34. SONG T, Kim MK, Jung YW, Yun BS, et al
    The role of appendectomy in patients with mucinous borderline ovarian tumors.
    Eur J Obstet Gynecol Reprod Biol. 2018;229:112-116.
    PubMed     Abstract available


    May 2018
  35. POUNDS R, Phillips A, Kehoe S, Nevin J, et al
    Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.
    Eur J Obstet Gynecol Reprod Biol. 2018;226:47-53.
    PubMed     Abstract available


    April 2018
  36. LOAEC C, Bats AS, Ngo C, Cornou C, et al
    Dual docking robotic surgical staging for high risk endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:79-83.
    PubMed     Abstract available


  37. LEVIN G, Zigron R, Haj-Yahya R, Matan LS, et al
    Granulosa cell tumor of ovary: A systematic review of recent evidence.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:57-61.
    PubMed    


  38. TIMMERMANS M, Sonke GS, van Driel WJ, Lalisang RI, et al
    Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
    Eur J Obstet Gynecol Reprod Biol. 2018;223:98-102.
    PubMed     Abstract available


    March 2018
  39. NTOUMANOGLOU-SCHUIKI A, Tomasch G, Laky R, Taumberger N, et al
    Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: What do national societies advise?
    Eur J Obstet Gynecol Reprod Biol. 2018;225:110-112.
    PubMed     Abstract available


  40. CAPOTE S, Sanchez-Iglesias JL, Cubo-Abert M, De la Torre J, et al
    Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2018 Mar 28. pii: S0301-2115(18)30154.
    PubMed    


  41. SADEGHI R
    Sentinel lymph node biopsy in ovarian cancers: Are intracervical injections necessary?
    Eur J Obstet Gynecol Reprod Biol. 2018 Mar 20. pii: S0301-2115(18)30128.
    PubMed    


  42. RAJANBABU A, Agarwal R
    A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
    Eur J Obstet Gynecol Reprod Biol. 2018;224:77-80.
    PubMed     Abstract available


  43. MENDIVIL AA, Abaid LN, Brown JV 3rd, Mori KM, et al
    The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;224:29-32.
    PubMed     Abstract available


    January 2018
  44. LI J, Zhu Q, Yang B, Ning C, et al
    Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2018;222:151-154.
    PubMed     Abstract available


  45. RUAN L, Xie Y, Liu F, Chen X, et al
    Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Eur J Obstet Gynecol Reprod Biol. 2018;222:31-38.
    PubMed     Abstract available


    December 2017
  46. DUFFY S, Day EK, Bryson G, Millan D, et al
    Malignant tumours arising within mature cystic teratomas of the ovary: Prevalence and clinical outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2017 Dec 21. pii: S0301-2115(17)30571.
    PubMed    


  47. VAN NIEKERK CC, van Dijck JAAM, Verbeek ALM
    The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    Eur J Obstet Gynecol Reprod Biol. 2017;221:17-22.
    PubMed     Abstract available


  48. UCCELLA S, Gisone B, Stevenazzi G, Ghezzi F, et al
    Laparoscopic sentinel node detection with ICG for early ovarian cancer: Description of a technique and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2017 Dec 6. pii: S0301-2115(17)30543.
    PubMed    


    November 2017
  49. VIMERCATI A, Suma C, Cicinelli E, Resta L, et al
    Title ultrasound features of ovarian melanoma metastases: The "Golf ball" aspect.
    Eur J Obstet Gynecol Reprod Biol. 2017 Nov 23. pii: S0301-2115(17)30511.
    PubMed     Abstract available


  50. CORMIO G, Seckl MJ, Loizzi V, Resta L, et al
    Increased human Chorionic Gonadotropin levels five years before diagnosis of an ovarian dysgerminoma.
    Eur J Obstet Gynecol Reprod Biol. 2017 Nov 10. pii: S0301-2115(17)30510.
    PubMed    


  51. ABBASI S, Rasouli M
    Dermatoglyphic patterns on fingers and gynecological cancers.
    Eur J Obstet Gynecol Reprod Biol. 2017;222:39-44.
    PubMed     Abstract available


    October 2017
  52. VERMEULEN CKM, Tadesse W, Timmermans M, Kruitwagen RFPM, et al
    Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;219:100-105.
    PubMed     Abstract available


  53. KURU O, Boyraz G, Uckan H, Erturk A, et al
    Retroperitoneal nodal metastasis in primary adult type granulosa cell tumor of the ovary: Can routine lymphadenectomy be omitted?
    Eur J Obstet Gynecol Reprod Biol. 2017;219:70-73.
    PubMed     Abstract available


    July 2017
  54. WEN Q, Shao Z, Zhang P, Zhu T, et al
    Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:85-91.
    PubMed     Abstract available


  55. CHENE G, Chauvy L, Buenerd A, Moret S, et al
    Dynamic real-time in vivo confocal laser endomicroscopy of the fallopian tube during laparoscopy in the prevention of ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:18-23.
    PubMed     Abstract available


    June 2017
  56. YILDIRIM N, Akman L, Acar K, Demir S, et al
    Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2017;215:55-61.
    PubMed     Abstract available


    May 2017
  57. GORDTS S, Campo R, Bogers JP, Tanos V, et al
    Transvaginal laparoscopy: A minimally invasive approach to obtain brush cytology of the Fallopian tube.
    Eur J Obstet Gynecol Reprod Biol. 2017;212:80-84.
    PubMed     Abstract available


    January 2017
  58. SAIJO M, Nakamura K, Masuyama H, Ida N, et al
    Glasgow prognostic score is a prognosis predictor for patients with endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;210:355-359.
    PubMed     Abstract available


    December 2016
  59. GHANEM AI, Khan NT, Mahan M, Ibrahim A, et al
    The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis.
    Eur J Obstet Gynecol Reprod Biol. 2016;210:225-230.
    PubMed     Abstract available


    November 2016
  60. ROMANOWICZ H, Michalska MM, Samulak D, Malinowski J, et al
    Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2016;208:36-40.
    PubMed     Abstract available


    October 2016
  61. KASPER SM, Dueholm M, Marinovskij E, Blaakaer J, et al
    Imaging diagnostics in ovarian cancer: magnetic resonance imaging and a scoring system guiding choice of primary treatment.
    Eur J Obstet Gynecol Reprod Biol. 2016;210:83-89.
    PubMed     Abstract available


  62. ISROW D, Burmeister C, Hanna RK, Elshaikh MA, et al
    Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:115-120.
    PubMed     Abstract available


  63. BAR D, Lavie O, Stein N, Feferkorn I, et al
    The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2016 Oct 14. pii: S0301-2115(16)30914.
    PubMed     Abstract available


  64. NI T, Sun X, Shan B, Wang J, et al
    Detection of circulating tumour cells may add value in endometrial cancer management.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:1-4.
    PubMed     Abstract available


  65. RUIZ M, Labauge P, Louboutin A, Limot O, et al
    External validation of the MR imaging scoring system for the management of adnexal masses.
    Eur J Obstet Gynecol Reprod Biol. 2016;205:115-9.
    PubMed     Abstract available


    August 2016
  66. RUIZ MP, Morales-Ramirez PB, Dziadek OL, Algren SD, et al
    Epithelial ovarian cancer and type of peritoneal insult: a case-control study.
    Eur J Obstet Gynecol Reprod Biol. 2016;205:170-173.
    PubMed     Abstract available


    June 2016
  67. RADHOUANE A, Mayada S, Khaled N
    Lymphangioma of the ovary: etiology and management.
    Eur J Obstet Gynecol Reprod Biol. 2016 Jun 29. pii: S0301-2115(16)30296.
    PubMed     Abstract available


  68. SINHA A, Drews F, Lim K, Pugh ND, et al
    Retrospective analysis of suspicious pelvic masses using the Pelvic Mass Index (PMI) scoring system from 2007 to 2014.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:79-84.
    PubMed     Abstract available


    May 2016
  69. GURASLAN H, Dogan K
    Management of unilocular or multilocular cysts more than 5 centimeters in postmenopausal women.
    Eur J Obstet Gynecol Reprod Biol. 2016;203:40-43.
    PubMed     Abstract available


    March 2016
  70. SHIBER LJ, Gregory EJ, Gaskins JT, Biscette SM, et al
    Adnexal masses requiring reoperation in women with previous hysterectomy with or without adnexectomy.
    Eur J Obstet Gynecol Reprod Biol. 2016;200:123-127.
    PubMed     Abstract available


    February 2016
  71. BUDA A, Ghelardi A, Fruscio R, Guelfi F, et al
    The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: a double institution observational study.
    Eur J Obstet Gynecol Reprod Biol. 2016;197:156-8.
    PubMed     Abstract available


    November 2015
  72. SECKIN KD, Karsli MF, Yucel B, Bestel M, et al
    The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
    Eur J Obstet Gynecol Reprod Biol. 2015;196:60-63.
    PubMed     Abstract available


    October 2015
  73. TJALMA WA
    Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2015 Oct 27. pii: S0301-2115(15)00363.
    PubMed    


    August 2015
  74. PECES RAMA A, Llanos Llanos MC, Sanchez Ferrer ML, Alcazar Zambrano JL, et al
    Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.
    Eur J Obstet Gynecol Reprod Biol. 2015;195:7-11.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: